 Participants: Following human ethics committee approval, and informed written consent, 180 patients undergoing elective cardiac surgery will be randomized to receive desflurane or propofol as the primary anaesthetic agent during surgery. This will be conducted at the Royal Melbourne Hospital. Data will be collected preoperatively, intraoperatively and throughout the entire hospital stay, and including a three-month follow-up. 